Generic Name and Formulations:
Oxazepam 10mg, 15mg, 30mg; caps.
Various generic manufacturers
Indications for Oxazepam:
Mild to moderate: 10–15mg 3–4 times daily. Severe: 15–30mg 3–4 times daily.
Renal, cardiovascular, or liver disease. Change dose gradually. Reevaluate periodically. Aspirin sensitivity (15mg tabs only). Monitor blood counts and liver function. Pregnancy, nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants.
CNS depression, drowsiness, dizziness, memory impairment, headache, ataxia, paradoxical excitement, hypotension, rash, nausea, edema, slurred speech, jaundice, blood dyscrasias, abuse potential.
Formerly known under the brand names Serax (caps, tabs); Zaxopam (caps).
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- The Caregivers' Cancer Journey
- Staff Education Leads to Increase in Oncology Rehabilitation Referrals
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Gender Bias in Medicine Has Far-Reaching Consequences
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Patient Interest in Melanoma Genetic Risk Testing is Fairly High
- Genetic Link Between Depression and Breast Cancer Remains Unclear
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|